BEVERLY, Mass., Aug. 18, 2016 /PRNewswire/ -- Axcelis
Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling
ion implantation solutions for the semiconductor industry,
announced the company's plans to participate in the Credit
Suisse 7th Annual US Small & Mid Cap Conference. The conference
is scheduled for September 14th in
New York City.
Axcelis management will host one-on-one meetings with interested
investors during the conference. For more information on the
conference or to schedule a one-on-one meeting, please contact a
Credit Suisse representative or the conference coordinator
at: brett.weiss@credit-suisse.com
About Axcelis:
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative,
high-productivity solutions for the semiconductor industry for over
35 years. Axcelis is dedicated to developing enabling process
applications through the design, manufacture and complete life
cycle support of ion implantation systems, one of the most critical
and enabling steps in the IC manufacturing process. Learn more
about Axcelis at www.axcelis.com.
CONTACTS:
Maureen Hart
(editorial/media) 978.787.4266
Doug Lawson (investor relations)
978.787.9552
Logo -
http://photos.prnewswire.com/prnh/20130905/NE75070LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/axcelis-to-present-at-the-credit-suisse-7th-annual-small--mid-cap-conference-300314978.html
SOURCE Axcelis Technologies, Inc.